871 related articles for article (PubMed ID: 24189199)
1. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
2. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
4. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
[TBL] [Abstract][Full Text] [Related]
7. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
8. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.
Impinen A; Longnecker MP; Nygaard UC; London SJ; Ferguson KK; Haug LS; Granum B
Environ Int; 2019 Mar; 124():462-472. PubMed ID: 30684804
[TBL] [Abstract][Full Text] [Related]
9. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
Jain RB; Ducatman A
Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
[TBL] [Abstract][Full Text] [Related]
10. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
[TBL] [Abstract][Full Text] [Related]
11. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
[TBL] [Abstract][Full Text] [Related]
12. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins.
Jain RB; Ducatman A
Sci Total Environ; 2019 Feb; 653():74-81. PubMed ID: 30408670
[TBL] [Abstract][Full Text] [Related]
13. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
[TBL] [Abstract][Full Text] [Related]
15. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
[TBL] [Abstract][Full Text] [Related]
16. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
[TBL] [Abstract][Full Text] [Related]
18. Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.
Mora AM; Fleisch AF; Rifas-Shiman SL; Woo Baidal JA; Pardo L; Webster TF; Calafat AM; Ye X; Oken E; Sagiv SK
Environ Int; 2018 Feb; 111():1-13. PubMed ID: 29156323
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011.
Okada E; Kashino I; Matsuura H; Sasaki S; Miyashita C; Yamamoto J; Ikeno T; Ito YM; Matsumura T; Tamakoshi A; Kishi R
Environ Int; 2013 Oct; 60():89-96. PubMed ID: 24013022
[TBL] [Abstract][Full Text] [Related]
20. Associations between Mixture of Perfluoroalkyl Substances and Lipid Profile in a Highly Exposed Adult Community in the Veneto Region.
Batzella E; Zare Jeddi M; Pitter G; Russo F; Fletcher T; Canova C
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
